When 'digoxin use' is not the same as 'digoxin use': lessons from the AFFIRM trial

Editorial

Sabina A Murphy. Eur Heart J. 2013 May.

. 2013 May;34(20):1465-7.

doi: 10.1093/eurheartj/eht087. Epub 2013 Apr 16.

No abstract available

Comment on

Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
Whitbeck MG, Charnigo RJ, Khairy P, Ziada K, Bailey AL, Zegarra MM, Shah J, Morales G, Macaulay T, Sorrell VL, Campbell CL, Gurley J, Anaya P, Nasr H, Bai R, Di Biase L, Booth DC, Jondeau G, Natale A, Roy D, Smyth S, Moliterno DJ, Elayi CS. Whitbeck MG, et al. Eur Heart J. 2013 May;34(20):1481-8. doi: 10.1093/eurheartj/ehs348. Epub 2012 Nov 27. Eur Heart J. 2013. PMID: 23186806 Clinical Trial.
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A. Gheorghiade M, et al. Eur Heart J. 2013 May;34(20):1489-97. doi: 10.1093/eurheartj/eht120. Epub 2013 Apr 16. Eur Heart J. 2013. PMID: 23592708 Free PMC article. Clinical Trial.